Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2018	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Jan 1, 2018	Dec 31, 2016	Dec 31, 2015
Pharmaceuticals	1.34B	1.15B	1.15B	1.09B	1.14B
Pharmaceuticals Growth	15.88%	0.56%	5.00%	-4.29%	-29.37%
Total	1.34B	1.15B	1.15B	1.09B	1.14B
Total Growth	15.88%	0.56%	5.00%	-4.29%	-29.37%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2018	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Jan 1, 2018	Dec 31, 2016	Dec 31, 2015
Northern China	497.76M	552.77M	496.66M	446.15M	491.06M
Northern China Growth	-9.95%	11.30%	11.32%	-9.15%	-
Northeast China	61.17M	20.17M	25.07M	25.57M	25.07M
Northeast China Growth	203.26%	-19.55%	-1.96%	2.01%	-
East China	307.60M	224.86M	270.81M	241.41M	264.76M
East China Growth	36.80%	-16.97%	12.18%	-8.82%	-
South Central China	280.25M	202.74M	160.64M	187.33M	188.74M
South Central China Growth	38.23%	26.21%	-14.25%	-0.75%	-
Southwest China	113.43M	90.83M	122.70M	126.51M	112.03M
Southwest China Growth	24.88%	-25.97%	-3.01%	12.92%	-
North-West China	73.55M	58.91M	66.95M	60.95M	53.13M
North-West China Growth	24.86%	-12.01%	9.85%	14.72%	-
Export	2.38M	2.75M	3.75M	4.02M	-
Export Growth	-13.64%	-26.57%	-6.64%	-	-
Others China	-	-	-	-	6.03M
Total	1.34B	1.15B	1.15B	1.09B	1.14B
Total Growth	15.88%	0.56%	5.00%	-4.29%	-29.37%

Source: S&P Global Market Intelligence.